Published in Hypertension on August 01, 2000
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson (2013) 3.52
Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation (2012) 2.41
Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J (2013) 2.21
Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound (2005) 1.34
Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J Mol Cell Cardiol (2013) 1.17
Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage. J Am Heart Assoc (2015) 1.00
The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography. Cardiovasc Ultrasound (2005) 0.86
Myocardial fibrosis: biomedical research from bench to bedside. Eur J Heart Fail (2017) 0.84
Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions. J Cardiovasc Transl Res (2013) 0.84
Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension. Heart (2005) 0.80
Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature. J Cell Mol Med (2010) 0.79
Evaluation of extracellular volume fraction thresholds corresponding to myocardial late-gadolinium enhancement using cardiac magnetic resonance. Int J Cardiovasc Imaging (2014) 0.78
Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc (2016) 0.78
Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement. J Cardiovasc Magn Reson (2016) 0.77
Magnetic resonance imaging for characterizing myocardial diseases. Int J Cardiovasc Imaging (2017) 0.76
An updated concept for left ventricular hypertrophy risk in hypertension. Ochsner J (2009) 0.76
Think Small and Examine the Constituents of Left Ventricular Hypertrophy and Heart Failure: Cardiomyocytes Versus Fibroblasts, Collagen, and Capillaries in the Interstitium. J Am Heart Assoc (2015) 0.75
Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure. Heart Vessels (2016) 0.75
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation (2017) 0.75
Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies. World J Cardiol (2014) 0.75
Sudden death is associated with a widened paced QRS complex in noncoronary cardiac disease. J Interv Card Electrophysiol (2006) 0.75
Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature (2000) 9.82
Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature (2005) 9.50
Mott transition in VO2 revealed by infrared spectroscopy and nano-imaging. Science (2007) 3.01
Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci U S A (2001) 2.96
Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty. Circulation (1999) 2.13
Beta-oxidation of 1-[14C]-17-[131I]-iodo-heptadecanoic acid following intracoronary injection in humans results in similar release of both tracers. Eur J Nucl Med (1993) 1.95
[Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. Dtsch Med Wochenschr (2001) 1.91
Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol (1997) 1.65
Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology (2002) 1.58
[Recurrent immune thrombocytopenia: a rare complication after contrast medium injection]. Dtsch Med Wochenschr (1995) 1.46
Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax. Cytotherapy (2008) 1.44
Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens (1996) 1.44
[Acute mitral insufficiency in osteogenesis imperfecta]. Dtsch Med Wochenschr (1994) 1.41
[Chemoreflex and baroreflex sensitivity in patients with survived sudden cardiac death]. Z Kardiol (1997) 1.41
Hemodynamic findings in patients with left bundle branch block after myectomy in hypertrophic obstructive cardiomyopathy (HOCM) Eur J Cardiothorac Surg (1993) 1.40
[Angina pectoris and a normal coronary angiogram in arterial hypertension and left ventricular hypertrophy]. Dtsch Med Wochenschr (1994) 1.39
[Changes in indications for surgical coronary revascularization 1985 to 1992]. Z Kardiol (1994) 1.39
[Repeated ingestion with suicidal intent of potentially lethal amounts of thallium]. Dtsch Med Wochenschr (1995) 1.39
[Sudden cardiac death in young men]. Dtsch Med Wochenschr (1996) 1.39
[The local lysis therapy of spontaneous renal artery dissection with arterial thrombosis]. Dtsch Med Wochenschr (1992) 1.38
Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation (2001) 1.37
[Can pathological left ventricular hypertrophy in arterial hypertension be distinguished from physiological hypertrophy caused by sports?]. Dtsch Med Wochenschr (2001) 1.37
Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med (1997) 1.32
Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. J Am Coll Cardiol (1998) 1.21
Automated ultrasonic measurement of human arteries for the determination of endothelial function. Ultraschall Med (2000) 1.20
Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway. Cardiovasc Res (1999) 1.19
Temperature-dependent evolution of the wetting layer thickness during Ge deposition on Si(001). Nanotechnology (2011) 1.17
Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve. Am J Cardiol (1979) 1.17
The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study. J Heart Valve Dis (1993) 1.16
Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol (1979) 1.15
Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg (1994) 1.14
Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). Clin Res Cardiol (2007) 1.13
Left ventricular systolic wall stress as a primary determinant of myocardial oxygen consumption: comparative studies in patients with normal left ventricular function, with pressure and volume overload and with coronary heart disease. Basic Res Cardiol (1977) 1.13
Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol (1991) 1.09
Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation (1993) 1.09
Diagnostic and therapeutic considerations in acute, severe mitral regurgitation: experience in 42 consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis (1993) 1.08
Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol (2000) 1.04
[A Q-fever pneumonia epidemic in Dusseldorf]. Pneumologie (1996) 1.01
Goose-mediated nutrient enrichment and planktonic grazer control in Arctic freshwater ponds. Oecologia (2007) 1.00
Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension (1996) 0.99
Arterial hypertension and cardiac arrhythmias. J Hypertens (2001) 0.96
Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J (1991) 0.96
Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. Eur Heart J (1994) 0.94
Lupus cardiomyopathy: cardiac mechanics, hemodynamics, and coronary blood flow in uncomplicated systemic lupus erythematosus. Am Heart J (1976) 0.93
[Changes in contractility during pressure and volume increase of the heart]. Verh Dtsch Ges Kreislaufforsch (1976) 0.92
Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction. J Cell Mol Med (2012) 0.92
[Inflammation of the myocardium as an arrhythmia trigger]. Z Kardiol (2000) 0.92
Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. Int Urol Nephrol (2001) 0.91
Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy. Virchows Arch (1997) 0.91
Contractile responses to morphine, piritramide, meperidine, and fentanyl: a comparative study of effects on the isolated ventricular myocardium. Anesthesiology (1972) 0.90
Evaluation of myocardial function with the 201thallium scintimetry in various diseases of the heart. A correlative study based on 100 patients. Eur J Nucl Med (1976) 0.90
Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. Eur Heart J (1984) 0.90
Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction. Z Kardiol (2004) 0.90
Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension (1995) 0.89
The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure. Intensive Care Med (1999) 0.89
Angiographic progression of coronary artery disease in patients with end-stage renal disease. Nephrol Dial Transplant (2001) 0.89
Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts. Am Heart J (1997) 0.89
Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol (1994) 0.89
Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease. Stem Cell Rev (2011) 0.89
[Reimbursement questions for cardiology services within the scope of GOA:2. Position of the DRG and GOA Project Group]. Z Kardiol (2003) 0.88
Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography. Heart (1997) 0.88
Evidence for an inefficient energy utilization in cardiac hypertrophy. Studies on the isolated human ventricular myocardium. Klin Wochenschr (1973) 0.88
Inotropic effects of Nifedipine: a new coronary dilating agent. Int J Clin Pharmacol (1974) 0.88
Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology (1994) 0.87
Comparison of myocardial oxygen consumption indices in man. Clin Cardiol (1980) 0.87
Disseminated microvascular pulmonary tumor cell embolism: a rare cause of fulminant pulmonary hypertension. Onkologie (2004) 0.87
[Coronary hemodynamics and myocardial oxygen consumption in patients with left-ventricular hypertrophy]. Z Kreislaufforsch (1972) 0.87
Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Ther (2012) 0.87
[Peripheral arterial complications after heart catheterization]. Herz (1998) 0.85
Multifactorial determination of 201thallium uptake of the heart: an experimental study concerning the influence of ventricular mass, perfusion and oxygen consumption. Basic Res Cardiol (1978) 0.85
Experimental hypothyroidism: depression of myocardial contractile function and hemodynamics and their reversibility by substitution with thyroid hormones. Basic Res Cardiol (1977) 0.85
[Ventricular function and coronary hemodynamics in essential hypertension]. Verh Dtsch Ges Kreislaufforsch (1977) 0.85
Morphometric investigation of intramyocardial arterioles in right septal endomyocardial biopsy of patients with arterial hypertension and left ventricular hypertrophy. J Cardiovasc Pharmacol (1992) 0.85
Ventricular function and coronary hemodynamics after intravenous nitroglycerin in coronary artery disease. Am Heart J (1978) 0.85
Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patients. Clin Res Cardiol (2006) 0.85
Blood rheology and hypertension in hemodialysis patients treated with erythropoietin. Am J Nephrol (1988) 0.85
Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab. Ann Hematol (2000) 0.85
Coronary haemodynamics in hypertensive heart disease. Eur Heart J (1992) 0.85
Release of endothelium derived nitric oxide in relation to pressure and flow. Cardiovasc Res (1991) 0.84
Experimental hyperthyroidism I. Hemodynamics and contractility in situ. Basic Res Cardiol (1975) 0.84
[Influence of various parameters of heart mechanics on oxygen consumption of the sufficient and insufficient left ventricle in aortic defects]. Verh Dtsch Ges Inn Med (1971) 0.84
Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure? Circ Res (1995) 0.84
[Hemodynamics, left ventricular volumes and compliance in 167 patients with congenital and acquired heart disease (author's transl)]. Klin Wochenschr (1975) 0.84
Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. Cardiovasc Res (1997) 0.84
[Results of 201thallium myocardial scanning in coronary heart disease (author's transl)]. Dtsch Med Wochenschr (1976) 0.84
Pathophysiology and clinical aspects of hypertensive hypertrophy. Eur Heart J (1993) 0.83
Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial. J Am Coll Cardiol (1996) 0.83
Experimental hyperthyroidism II. Mechanics of contraction and relaxation of isolated ventricular myocardium. Basic Res Cardiol (1975) 0.83
Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction. Hypertension (1996) 0.83
Endogenous plasma endothelin concentrations and coronary circulation in patients with mild dilated cardiomyopathy. Heart (1999) 0.83
Peripheral vascular effects of beta-blockers. Eur Heart J (1994) 0.83
[Mechanism of nitroglycerine effect from the aspect of myocardial contractility. Experimental animal studies on the isolated human ventricular myocardium]. Z Kardiol (1973) 0.83
Methylprednisolone in chronic myocarditis. Postgrad Med J (1994) 0.83
Additive effect of coexistent type 2 diabetes and arterial hypertension on endothelial dysfunction in resistance arteries of human forearm vasculature. Angiology (2000) 0.82
Mechanisms of histamine-induced coronary vasodilatation: H1-receptor-mediated release of endothelium-derived nitric oxide. J Vasc Res (1993) 0.82
A molecular basis for how a single TCR interfaces multiple ligands. J Immunol (1998) 0.82
Chemoreflexsensitivity in chronic heart failure patients. Eur J Heart Fail (2001) 0.82